Insights from the Antidote database on type 1 diabetes [whitepaper]
Type 1 diabetes (T1D) is a chronic, autoimmune disease that occurs when the body mistakenly attacks the pancreatic cells that create insulin. Without insulin, the body can’t process glucose, which can result in extreme blood sugar swings, excessive thirst and hunger, extreme fatigue, and more. Though it is often called “juvenile diabetes,” T1D can occur at any age and is estimated to impact nearly 2 million Americans.
Managing type 1 diabetes differs from many other medical conditions, as the onus is typically on the patient to monitor blood sugar, determine insulin doses, and gauge how stress and physical activity can impact their needs. Due to this, T1D has a significant effect on a person’s quality of life — but it also highlights the potential for research to bring about transformative improvements in the lives of patients.
In our latest whitepaper, we’re sharing valuable insights we’ve gathered from type 1 diabetes patients in our database. The data we’ve collected provides a better understanding of potential research participants, including their demographic makeup, patient concerns, research participation motivators, and the typical challenges individuals face. All of this information can educate researchers on how to design study protocols with the right inclusion and exclusion criteria, which can result in faster, more impactful research to improve T1D patients’ lives. To learn more about our insights, click the button below.